脫氫表雄酮 DHEA × 男性不孕

結論:證據不足

The evidence base for DHEA in MALE infertility is essentially absent.

U ⚫ U 未驗證 證據不足 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ stale 🇹🇼 台灣在地警示
⚗️ 研究進行中:本主題證據仍在累積、尚無定論;部分介入屬試驗階段,未必已在台上市或可購得。

The evidence base for DHEA in MALE infertility is essentially absent. PubMed (L2) located no randomized intervention trial in actual infertile or oligospermic men; the only RCT touching the male reproductive axis is Acacio 2000 (PMID 15037408), a 3-month study of just 11 healthy non-infertile men that found no change in semen parameters and explicitly warned that longer duration or higher doses could exert toxic effects on the reproductive axis. Examine has no male-infertility block for DHEA (coverage gap, found_in_examine=false), and the joint AUA/ASRM Male Infertility Guideline does not mention DHEA anywhere. DHEA's documented reproductive-medicine role is for FEMALE diminished ovarian reserve / IVF, not male-factor infertility, so there is a clear evidence-to-indication mismatch. With no positive RCT, no society endorsement, a possible (theoretical) harm signal from androgenic gonadotropin suppression, and no clinical endpoint data, the only honest grade is U (insufficient/ungraded evidence).

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.40
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
U · 證據不足
信心度
77%
證據方向大致一致
證據層級
E7
單篇小型隨機對照試驗

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.20
L2 PubMed原始文獻
0.40
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L5 臨床機構權威立場
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.396
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — D 級條件未達 (需 E1-E3 negative;實際 E7)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men
PMID: 15037408 2004 隨機對照試驗 n = 11
結論:DHEA administration to healthy men raised DHEA, DHEAS, 3-androstanediol glucuronide and LH levels, but produced NO change in testosterone, estradiol, or semen parameters; authors warned that longer duration or higher doses could exert more toxic changes on the reproductive axis.
🟠 品質有限 效應量:No measurable effect on semen parameters at 3 months
前往 PubMed
Sperm concentration is poorly associated with hypoandrogenism in infertile men
PMID: 25735445 2015 Cross-sectional n = 94
結論:Sperm concentration (normospermia, oligozoospermia, azoospermia) was not associated with biochemical hypoandrogenism; the study evaluated testosterone status, not DHEA supplementation, and is only tangentially relevant.
🟠 品質有限 效應量:Not applicable (observational, no DHEA arm)
前往 PubMed

L4a US FDA
謹慎
Intrarosa (prasterone) is the first FDA-approved product containing the active ingredient prasterone, also known as dehydroepiandrosterone (DHEA). 來源↗
L4b EU EFSA
反對
L4c UK NHS
反對
DHEA is classed as a prescription-only medicine in the UK and is also a Class C controlled drug. 來源↗
L4d TW TFDA / 衛福部
反對
DHEA(脫氫表雄酮)在台灣屬於藥品列管,不論劑量高低均以藥品管理,須由醫師開立處方;不得作為食品或膳食補充劑販售。 來源↗
L4e WHO
謹慎
DHEA is included in the pharmacological class S1 'Anabolic Agents' as an Anabolic Androgenic Steroid, prohibited at all times (in and out of competition) under the World Anti-Doping Code. 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群(PTT GoodPregnan、Dcard 親子/備孕)對 DHEA 的討論幾乎全集中在女性卵巢早衰、低 AMH、試管養卵;針對男性不孕/精蟲品質幾乎沒有實質實測討論,僅少數提到睪固酮偏低者經醫師建議補充,多為夫妻一起吃的附帶提及。男性精液參數改善的鄉民心得缺乏。

💬社群實感

無共識(男性不孕方向幾乎無在地實測討論;DHEA 在社群被普遍視為女性養卵用品,男性精蟲改善心得極少)

破解迷思 社群最常見的 3 個誤解
事實把 DHEA 對女性卵子品質的討論直接套用到男性,誤以為同樣能改善精蟲品質(缺乏在地實測佐證)
事實誤以為「天然山藥萃取 DHEA」就無副作用、可長期自行補充(DHEA 仍為荷爾蒙前驅物,仍有副作用與內分泌干擾風險)
事實誤把 DHEA 當睪固酮替代品來『補男性荷爾蒙』,忽略其轉換受個體酵素活性影響、結果難預期
🩹 社群通報的副作用
  • 掉髮
  • 皮膚出油/長痘
  • 腸胃不適、脹氣、胃酸
  • 亂經(女性)
  • 體毛增加、聲音變粗等男性化反應(女性使用者反映)
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • 特補樂
  • 賜汝蒙
  • 思孕蒙
  • 倍韻

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

脫氫表雄酮(DHEA)不分劑量都視為藥品

代表來源 ↗
L10b · TFDA 法定身份 官方認定

脫氫表雄酮(DHEA)不分劑量都視為藥品

來源 ↗

  • 顯微精索靜脈曲張手術
  • 輔助生殖技術(IUI/IVF/ICSI)
  • 生活型態與危險因子調整
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 2 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-male-infertility-INT-dehydroepiandrosterone-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-male-infertility-INT-dehydroepiandrosterone-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "脫氫表雄酮能改善男性不孕",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "alternateName": "證據不足 (Insufficient evidence)"
  }
}